CoreX is applying a disruptive bio-AI approach to revolutionize drug development: we use Patients-on-a-Chip to generate a massive proprietary dataset that is automated, highly predictive, and uses classification algorithms to train the machine learning model to better predict which drug candidates will safely work in humans.